Matches in Wikidata for { <http://www.wikidata.org/entity/Q61921320> ?p ?o ?g. }
Showing items 1 to 44 of
44
with 100 items per page.
- Q61921320 description "assaig clínic" @default.
- Q61921320 description "clinical trial" @default.
- Q61921320 description "clinical trial" @default.
- Q61921320 description "clinical trial" @default.
- Q61921320 description "clinical trial" @default.
- Q61921320 description "ensaio clínico" @default.
- Q61921320 description "ensayo clínico" @default.
- Q61921320 description "ensayu clínicu" @default.
- Q61921320 description "essai clinique" @default.
- Q61921320 description "klinisch onderzoek" @default.
- Q61921320 description "клінічне випробування" @default.
- Q61921320 description "临床试验" @default.
- Q61921320 name "Safety and Efficacy of Single Agent Obatoclax Mesylate (GX15-070MS) Followed by a Combination With Rituximab for Previously-untreated Follicular Lymphoma (FL)" @default.
- Q61921320 type Item @default.
- Q61921320 label "Safety and Efficacy of Single Agent Obatoclax Mesylate (GX15-070MS) Followed by a Combination With Rituximab for Previously-untreated Follicular Lymphoma (FL)" @default.
- Q61921320 prefLabel "Safety and Efficacy of Single Agent Obatoclax Mesylate (GX15-070MS) Followed by a Combination With Rituximab for Previously-untreated Follicular Lymphoma (FL)" @default.
- Q61921320 P1050 Q61921320-B2F44C05-F101-444E-BCBA-41CB64564D6A @default.
- Q61921320 P1132 Q61921320-648D753F-D43F-4A76-A99C-263CBD9E318E @default.
- Q61921320 P1476 Q61921320-C29958F1-21FF-44AD-9E20-07DB133330E3 @default.
- Q61921320 P17 Q61921320-73257315-D1C4-444E-9C37-031784175ECC @default.
- Q61921320 P2899 Q61921320-8AFE73CA-6186-4963-B2D3-88BB80E38605 @default.
- Q61921320 P3098 Q61921320-AE5B0B42-9533-4917-A8F7-C685622C9BBD @default.
- Q61921320 P31 Q61921320-FA056567-9583-49DB-9524-DE253211F641 @default.
- Q61921320 P4844 Q61921320-67219A5D-2DCC-4DF1-AD35-3D7DDECFE779 @default.
- Q61921320 P580 Q61921320-8E97BCA0-48AE-41EC-ABD1-FAE44E90CD32 @default.
- Q61921320 P582 Q61921320-1404BCC6-8F38-449B-BA96-DECACEC11D35 @default.
- Q61921320 P6099 Q61921320-6EA5EB14-72F7-4772-ADD2-AE0C087F6CAB @default.
- Q61921320 P6153 Q61921320-AF4DC3EF-1F05-482B-87EA-500656945E82 @default.
- Q61921320 P8005 Q61921320-F502199C-3A18-455A-9CB3-E18F894A5F7D @default.
- Q61921320 P8363 Q61921320-2029DF96-5A47-4036-A0EF-DAEF32A9C2E8 @default.
- Q61921320 P1050 Q208414 @default.
- Q61921320 P1132 "+7" @default.
- Q61921320 P1476 "A Multi-Center, Open-Label, Phase II Study of Sequential, Single-Agent Obatoclax Mesylate (GX15-070MS)Followed by a Combination With Rituximab to Patients With Previously-Untreated Follicular Lymphoma (FL)" @default.
- Q61921320 P17 Q30 @default.
- Q61921320 P2899 "+18" @default.
- Q61921320 P3098 "NCT00427856" @default.
- Q61921320 P31 Q30612 @default.
- Q61921320 P4844 Q412323 @default.
- Q61921320 P580 "2007-03-01T00:00:00Z" @default.
- Q61921320 P582 "2009-02-01T00:00:00Z" @default.
- Q61921320 P6099 Q42824440 @default.
- Q61921320 P6153 Q5637237 @default.
- Q61921320 P8005 Q76651189 @default.
- Q61921320 P8363 Q78089383 @default.